Schrödinger, Inc.
General ticker "SDGR" information:
- Sector: Health Care
- Industry: Medical - Healthcare Information Services
- Capitalization: $1.3B (TTM average)
Schrödinger, Inc. follows the US Stock Market performance with the rate: 15.3%.
Estimated limits based on current volatility of 3.0%: low 19.66$, high 20.88$
Factors to consider:
- Total employees count: 891 (+2.8%) as of 2024
- US accounted for 55.3% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Operating losses, Collection risk, Software defects, Third-party risks, Geopolitical risks
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [14.27$, 27.79$]
- 2026-12-31 to 2027-12-31 estimated range: [13.44$, 26.53$]
Financial Metrics affecting the SDGR estimates:
- Negative: with PPE of -12.9 at the end of fiscal year the price was high
- Negative: negative Operating income
- Positive: 42.26 < Shareholder equity ratio, % of 50.13 <= 63.63
- Positive: 0.28 < Operating cash flow per share per price, % of 1.03
- Negative: negative Net income
- Positive: Investing cash flow per share per price, % of 4.30 > -0.64
Short-term SDGR quotes
Long-term SDGR plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $216.67MM | $207.54MM | $255.87MM |
| Operating Expenses | $394.11MM | $416.83MM | $422.76MM |
| Operating Income | $-177.45MM | $-209.30MM | $-166.90MM |
| Non-Operating Income | $220.37MM | $23.59MM | $64.57MM |
| R&D Expense | $181.77MM | $201.78MM | $173.14MM |
| Income(Loss) | $42.92MM | $-185.71MM | $-102.33MM |
| Taxes | $2.20MM | $1.41MM | $0.94MM |
| Net Income(Loss)* | $40.72MM | $-187.12MM | $-103.27MM |
| Stockholders Equity | $548.56MM | $421.44MM | $364.05MM |
| Assets | $802.96MM | $823.23MM | $726.16MM |
| Operating Cash Flow | $-136.73MM | $-157.37MM | $13.90MM |
| Capital expenditure | $13.40MM | $7.31MM | $1.44MM |
| Investing Cash Flow | $193.03MM | $148.84MM | $57.90MM |
| Financing Cash Flow | $9.05MM | $10.12MM | $2.93MM |
| Earnings Per Share** | $0.57 | $-2.57 | $-1.41 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.